The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Trehalose rescues Alzheimer's disease phenotypes in APP/PS1 transgenic mice
Abstract
Objective: Alzheimer's Disease (AD) is well characterized by the accumulated Aβ plaque in hippocampus and cerebral cortex concomitant with markedly reduced study and learning ability. Trehalose, a natural disaccharide, has been shown to have neural protective properties and exhibited therapeutic effects in animal models of several neural degenerative disorders. However, the effect of trehalose on AD pathology remains largely unknown. Methods: In this study, we evaluated the effects of trehalose in APP/PS1 transgenic mice through behaviour tests and biochemical analyses. Key findings: We found that the impaired cognitive and learning ability was improved and Aβ deposit in hippocampus was reduced. Conclusions: These results suggested that trehalose could be a potential therapeutic drug for the treatment of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and has also been shown to reduce protein aggregates in a number of other neurodegenerative diseases [62–66].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases
Selkoe, D. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1054 · Cited by 863
Casarejos, M. J., Solano, R. M., Gómez, A., Perucho, J., de Yébenes, J. G., & Mena, M. A. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.01.008 · Cited by 114 · cited 1×
“Besides the selective targeting to Ab peptide, the activation of autophagy also helps explain the neural protective activity of trehalose by enhanced clearance of tau and other neurotoxic proteins, which is confirmed in primary cultured neurons,([6]) in human neuroblastoma cells([7]) and tauopathy model mice.”
Background
Research works printed but not linked: 6
- Tanaka, 2004, Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease, Nat Med, 10, 148, 10.1038/nm985 · DOI · Paper page
- Rodríguez-Navarro, 2010, Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation, Neurobiol Dis, 39, 423, 10.1016/j.nbd.2010.05.014 · DOI · Paper page
- Du, 2009, Metabolites of cerebellar neurons and hippocampal neurons play opposite roles in pathogenesis of Alzheimer's disease, PLoS ONE, 4, e5530, 10.1371/journal.pone.0005530 · DOI
- Reddy, 2009, Effect of trehalose on amyloid beta (29-40)-membrane interaction, J Chem Phys, 131, 10.1063/1.3193726 · DOI
- Krüger, 2012, Autophagic degradation of tau in primary neurons and its enhancement by trehalose, Neurobiol Aging, 33, 2291, 10.1016/j.neurobiolaging.2011.11.009 · DOI · Paper page
- Janus, 2000, Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes, Neurobiol Aging, 21, 541, 10.1016/S0197-4580(00)00107-X · DOI
Cited by
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities
Menzies, F. M., Fleming, A., Caricasole, A., Bento, C. F., Andrews, S. P., Ashkenazi, A., Füllgrabe, J., Jackson, A., Jimenez Sanchez, M., Karabiyik, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.01.022 · Cited by 1,134
Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
Boland, B., Yu, W. H., Corti, O., Mollereau, B., Henriques, A., Bezard, E., Pastores, G. M., Rubinsztein, D. C., Nixon, R. A., Duchen, M. R., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.109 · Cited by 558
Autophagy in neurodegenerative diseases: pathogenesis and therapy
Guo, F., Liu, X., Cai, H., & Le, W. (2018) · Brain Pathology · doi:10.1111/bpa.12545 · Cited by 444
Rusmini, P., Cortese, K., Crippa, V., Cristofani, R., Cicardi, M. E., Ferrari, V., Vezzoli, G., Tedesco, B., Meroni, M., Messi, E., et al. (2019) · Autophagy · doi:10.1080/15548627.2018.1535292 · Cited by 436
“The analogs melibiose and lactulose mimic the pro-autophagic effects of trehalose Trehalose effects have already been assayed in several different mice models of NDs linked to misfolded protein neurotoxicity with promising results [11,15-19,21-25].”
BackgroundAutophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
Uddin, M. S., Stachowiak, A., Mamun, A. A., Tzvetkov, N. T., Takeda, S., Atanasov, A. G., Bergantin, L. B., Abdel-Daim, M. M., & Stankiewicz, A. M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00004 · Cited by 395
Metadata
- Authors
- Du, J., Liang, Y., Xu, F., Sun, B., & Wang, Z.
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-12-01
- Volume
- 65
- Issue
- 12
- Pages
- 1753-1756
- ISSN
- 2042-7158
- 0022-3573
- Cited by
- 129
- References
- 4
- Language
- en
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Funders
- National Natural Science Foundation of China (31000418, 81270425)
- National Basic Research Program (973 Project) of China (2007CB507406)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trehalose rescues Alzheimer's disease phenotypes in APP/PS1 transgenic mice. https://app.cochat.ai/papers/10.1111/jphp.12108
- The paper
- Du, J., Liang, Y., Xu, F., Sun, B., & Wang, Z. (2013). Trehalose rescues Alzheimer's disease phenotypes in APP/PS1 transgenic mice. Journal of Pharmacy and Pharmacology. https://doi.org/10.1111/jphp.12108
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.